Accord Healthcare Launches Fluorouracil in Australia

Accord Healthcare Launches Fluorouracil in Australia

Accord is pleased to announce that it has recently launched Fluorouracil in Australia.  This continues Accord’s growth in the oncology segment and provides valuable additional supply for the Australian market.  The following SKUs are now available via Symbion:

  • 1000mg/20mL

  • 2500mg/50mL

  • 5000mg/100mL